Received Mar 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | — |
feeling like she had the flu with aches; Pain injection site; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix .5 ml. On an unknown date, an unknown time after receiving Shingrix, the patient experienced injection site pain (Verbatim: Pain injection site) and influenza-like symptoms (Verbatim: feeling like she had the flu with aches). The outcome of the injection site pain was resolved (duration 2 months) and the outcome of the influenza-like symptoms was resolved. It was unknown if the reporter considered the injection site pain and influenza-like symptoms to be related to Shingrix. It was unknown if the company considered the injection site pain and influenza-like symptoms to be related to Shingrix. Additional Information: GSK Receipt Date: 10-MAR-2025 The patient self-reported this case. The patient had received 1st dose of Shingrix vaccine in 2022 and in 2022 due to feeling like she had the flu with aches and pains and pain at the injection site, she did not went back for the second vaccine within the recommended schedule time. The patient stated that she did not remember much about the things she experienced with the first dose. She did remember that the injection site pain lasted for about 2 months before it resolved. The patient did not remember what medications she was taking during the 1st dose in 2022.